Edesa Biotech Inc banner

Edesa Biotech Inc
NASDAQ:EDSA

Watchlist Manager
Edesa Biotech Inc Logo
Edesa Biotech Inc
NASDAQ:EDSA
Watchlist
Price: 5.9 USD 6.88% Market Closed
Market Cap: $49.3m

Balance Sheet

Balance Sheet Decomposition
Edesa Biotech Inc

Balance Sheet
Edesa Biotech Inc

Rotate your device to view
Balance Sheet
Currency: USD
Apr-2008 Apr-2009 Aug-2010 Aug-2011 Aug-2012 Aug-2013 Aug-2014 Sep-2015 Sep-2016 Sep-2017 Sep-2018 Sep-2019 Sep-2020 Sep-2021 Sep-2022 Sep-2023 Sep-2024 Sep-2025
Assets
Cash & Cash Equivalents
0
0
2
4
1
8
13
4
7
5
4
5
7
8
7
5
1
11
Cash
0
0
0
3
1
0
0
0
0
0
4
0
0
0
0
0
0
0
Cash Equivalents
0
0
2
1
0
8
13
4
7
5
1
5
7
8
7
5
1
11
Short-Term Investments
0
0
0
0
0
0
0
5
4
2
6
0
0
0
0
0
0
0
Total Receivables
0
0
1
0
0
0
0
0
0
0
0
0
0
3
1
1
0
1
Accounts Receivables
0
0
1
0
0
0
0
0
0
0
0
0
0
3
1
1
0
1
Other Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Inventory
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
Other Current Assets
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
0
0
0
Total Current Assets
0
0
3
4
1
8
14
10
12
7
11
6
8
12
9
6
2
12
PP&E Net
0
0
0
0
0
0
0
1
1
1
1
0
0
0
0
0
0
0
PP&E Gross
0
0
0
0
0
0
0
1
1
0
1
0
0
0
0
0
0
0
Accumulated Depreciation
0
0
0
0
0
0
1
1
1
0
1
0
0
0
0
0
0
0
Intangible Assets
0
0
0
0
0
0
0
0
0
0
0
0
2
2
2
2
2
2
Long-Term Investments
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Assets
0
N/A
0
+137%
3
+1 318%
5
+64%
2
-68%
9
+451%
14
+70%
10
-28%
13
+25%
8
-40%
12
+53%
6
-51%
11
+88%
15
+36%
12
-21%
9
-23%
4
-57%
14
+255%
Liabilities
Accounts Payable
0
0
0
0
0
0
1
1
1
0
0
0
1
1
2
2
2
1
Accrued Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
0
0
0
0
0
3
1
2
0
0
0
0
0
0
0
0
0
0
Total Current Liabilities
0
0
0
0
1
4
1
2
1
0
0
0
2
1
2
2
2
1
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
2
0
7
5
0
0
0
0
0
0
0
0
0
0
0
Total Liabilities
0
N/A
0
N/A
0
N/A
2
+301%
1
-59%
11
+1 448%
7
-37%
2
-65%
1
-74%
0
-49%
0
+54%
0
-6%
2
+258%
2
-8%
2
+43%
2
-16%
2
0%
1
-41%
Equity
Common Stock
0
0
3
7
8
13
36
38
47
48
57
12
21
35
42
47
47
64
Retained Earnings
0
0
1
4
9
25
34
35
40
45
50
7
13
26
44
52
59
66
Additional Paid In Capital
0
0
1
0
0
5
0
0
0
0
0
0
2
5
11
13
14
15
Other Equity
0
0
0
1
1
5
5
5
5
4
5
0
0
0
0
0
0
0
Total Equity
0
N/A
0
+162%
2
+1 112%
3
+24%
1
-72%
2
N/A
8
N/A
8
+4%
12
+54%
7
-40%
11
+53%
5
-53%
9
+73%
13
+43%
9
-28%
7
-25%
2
-72%
12
+529%
Total Liabilities & Equity
0
N/A
0
+134%
3
+1 318%
5
+64%
2
-68%
9
+451%
14
+70%
10
-28%
13
+25%
8
-40%
12
+53%
6
-51%
11
+88%
15
+36%
12
-21%
9
-23%
4
-57%
14
+255%
Shares Outstanding
Common Shares Outstanding
0
0
0
0
0
0
0
0
0
0
1
1
1
2
2
3
3
7
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett